These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25359383)

  • 21. Significance of IgA antiphospholipid antibodies.
    Wilson WA; Faghiri Z; Taheri F; Gharavi AE
    Lupus; 1998; 7 Suppl 2():S110-3. PubMed ID: 9814686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reality Check on Antiphospholipid Antibodies in COVID-19-Associated Coagulopathy.
    Gkrouzman E; Barbhaiya M; Erkan D; Lockshin MD
    Arthritis Rheumatol; 2021 Jan; 73(1):173-174. PubMed ID: 32901454
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
    Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
    Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is There an Additional Value in Detecting Anticardiolipin and Anti-β2 glycoprotein I IgA Antibodies in the Antiphospholipid Syndrome?
    Chayoua W; Yin DM; Kelchtermans H; Moore GW; Gris JC; Musiał J; Zuily S; Ten Cate H; de Laat B; Devreese KMJ
    Thromb Haemost; 2020 Nov; 120(11):1557-1568. PubMed ID: 32696448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [New insights on disorders of haemostasis in the antiphospholipid syndrome].
    Zawilska K
    Pol Arch Med Wewn; 2006 May; 115(5):491-9. PubMed ID: 17195368
    [No Abstract]   [Full Text] [Related]  

  • 26. Novel enzyme immunoassay system for simultaneous detection of six subclasses of antiphospholipid antibodies for differential diagnosis of antiphospholipid syndrome.
    Nojima J; Motoki Y; Hara K; Sakata T; Ichihara K
    Blood Coagul Fibrinolysis; 2017 Jun; 28(4):316-322. PubMed ID: 27676644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
    Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M
    J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiphospholipid syndrome without antiphospholipid antibodies at the time of the thrombotic event: transient 'seronegative' antiphospholipid syndrome?
    Miret C; Cervera R; Reverter JC; García-Carrasco M; Ramos M; Mollà M; Font J; Ingelmo M
    Clin Exp Rheumatol; 1997; 15(5):541-4. PubMed ID: 9307863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of IgA anticardiolipin and anti-beta2-GP1 antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.
    Samarkos M; Davies KA; Gordon C; Loizou S
    Clin Rheumatol; 2006 Mar; 25(2):199-204. PubMed ID: 16091839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Different Test Systems for the Detection of Antiphospholipid Antibodies in a Chinese Cohort.
    Hu C; Li S; Xie Z; You H; Jiang H; Shi Y; Qi W; Zhao J; Wang Q; Tian X; Li M; Zhao Y; Zeng X
    Front Immunol; 2021; 12():648881. PubMed ID: 34276646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interest of IgG and IgM antiprothrombin autoantibodies in the exploration of antiphospholipid syndrome: a 5-year retrospective study.
    Bertin D; Beziane A; Resseguier N; Pelissier M; Morange PE; Mege JL; Bardin N
    Rheumatology (Oxford); 2020 Jul; 59(7):1539-1544. PubMed ID: 31630203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary, secondary, and catastrophic antiphospholipid syndrome: what's in a name?
    Harris EN; Pierangeli SS
    Semin Thromb Hemost; 2008 Apr; 34(3):219-26. PubMed ID: 18720301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of antiphospholipid antibodies in patients with overt myocardial dysfunction in systemic lupus erythematosus. A case-control study.
    Gawalkar AA; Bahl A; Ahluwalia J; Sood A; Sharma A; Sharma S; Dhir V
    Lupus; 2020 Oct; 29(12):1503-1508. PubMed ID: 32752919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-17/Interleukin-21 and Interferon-γ producing T cells specific for β2 Glycoprotein I in atherosclerosis inflammation of systemic lupus erythematosus patients with antiphospholipid syndrome.
    Benagiano M; Borghi MO; Romagnoli J; Mahler M; Bella CD; Grassi A; Capitani N; Emmi G; Troilo A; Silvestri E; Emmi L; Alnwaisri H; Bitetti J; Tapinassi S; Prisco D; Baldari CT; Meroni PL; D'Elios MM
    Haematologica; 2019 Dec; 104(12):2519-2527. PubMed ID: 30872365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual.
    Frodlund M; Vikerfors A; Grosso G; Skogh T; Wetterö J; Elvin K; Gunnarsson I; Kastbom A; Dahlström Ö; Rönnelid J; Svenungsson E; Sjöwall C
    Clin Exp Immunol; 2018 Oct; 194(1):27-38. PubMed ID: 30208508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phospholipid-dependent anti-beta 2-glycoprotein I (beta 2-GPI) antibodies and antiphospholipid syndrome.
    Kaburaki J; Kuwana M; Yamamoto M; Kawai S; Matsuura E; Ikeda Y
    Intern Med; 1996 Feb; 35(2):105-10. PubMed ID: 8680096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome.
    Pericleous C; Ferreira I; Borghi O; Pregnolato F; McDonnell T; Garza-Garcia A; Driscoll P; Pierangeli S; Isenberg D; Ioannou Y; Giles I; Meroni PL; Rahman A
    PLoS One; 2016; 11(6):e0156407. PubMed ID: 27253369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticardiolipin and anti-beta 2 glycoprotein-I antibodies disappearance in patients with systemic lupus erythematosus and antiphospholipid syndrome while on belimumab.
    Sciascia S; Rubini E; Radin M; Cecchi I; Rossi D; Roccatello D
    Ann Rheum Dis; 2018 Nov; 77(11):1694-1695. PubMed ID: 29776976
    [No Abstract]   [Full Text] [Related]  

  • 40. Persistent Moderate-to-High Levels of Isolated Anticardiolipin Antibody IgA or Anti-β
    Keleşoğlu Dinçer AB; Thaler J; Erkan D
    Turk J Haematol; 2024 May; 41(2):121-122. PubMed ID: 38409786
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.